Biocept and Aegea Biotechnologies have entered into an agreement to co-develop a highly sensitive PCR-based assay, designed by Aegea, to detect the Covid-19 virus. The assay will be based on the Switch-Blocker technology used in Biocept’s oncology-focused assays. The test is expected to boost the sensitivity to detect Covid-19-causing SARS-CoV-2 virus and to offer additional information on specific types of strains.
Neura has adopted the ViruScore Covid-19 predictive testing solution. The Human Behavioral Intelligence Platform is said to be the first artificial intelligence-based approach that is used in the field, with HY Laboratories being the main provider of Covid-19 tests solutions in Israel, and using it to grade testing samples to enable efficient test pooling.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Mopec is providing ready-to-ship personal protective equipment (PPE) in response to the ongoing global Covid-19 pandemic. The PPE includes products that are FDA- and CE-compliant, which includes face shields, three-ply and KN95 masks, infrared thermometers, and hand sanitisers. The company’s PPE offerings are a part of its Guardian Systems line of Covid-19 preparation and response products.
VentilatorSOS has shipped sleep apnea devices to the hot spots of the pandemic to aid in the fight against Covid-19. The organisation developed the design to modify unused sleep apnea devices to address the need for ventilators. These shipments are expected to aid patients with Covid-19 in Ecuador, Haiti and Malawi. The VentilatorSOS is searching for a partner to meet the increasing needs around the globe with the millions of unused sleep apnea machines in the US which can be modified.
